[1]
“Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway”, Braz. J. Pharm. Sci., vol. 58, Nov. 2022, doi: 10.1590/s2175-97902022e191102.